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ABSTRACT 
Objective: The present study investigates the efficacy of DiaKure, a poly herbal formulation composed of powder of different herbs on blood 
glucose level of normal and diabetic rats. 
Methods: The raw materials were collected made it into a powder formulation. Streptozotocin 
Results: At a dose of 200 and 300 mg/kg p. o., DiaKure showed a hypoglycemic effect at a varying degree of significance (P<0.05-0.001) in normal 
rats in comparison with the respective control group. Maximum effect of DiaKure treatment in the glucose tolerance test occurred at 120
60 mg/kg was administered as a single i. p. Injection 
for induction of type 1 diabetes. After one week of streptozotocin injection, animals showing glycosuria (fasting blood sugar level>200 mg/dL) were 
considered as diabetic. The hypoglycemic activity and glucose tolerance test were studied in normal and Streptozotocin-induced diabetic rats after 
administration of DiaKure at a dose of 300 mg/kg. Blood glucose was determined by a glucose monitor. 
th
Conclusion: The results indicate significant hypoglycemic activity of DiaKure in male albino rats. 
minute of 
glucose administration in normal rats. 
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INTRODUCTION 
Diabetes mellitus describes a metabolic disorder of multiple 
etiologies characterized by chronic hyperglycemia with disturbances 
of carbohydrate, fat and protein metabolism resulting from defects 
in insulin secretion, insulin action, or both. The number of people 
suffering from diabetes has soared to 246 million and the disease 
now kills more people than AIDS [1]. It is a common disorder among 
the Indian population. Worldwide incidence of diabetes in the general 
population is 5%. It is estimated that there are 171 million people in 
the world with diabetes in the year 2000 and this is likely to increase 
up to 366 million by 2030[2]. As the number of the people with 
diabetes multiplies worldwide, the disease has taken an ever-
increasing share of national and international healthcare budgets. 
In day-to-day practice, most of the diabetic patients were treated 
with standard anti-diabetic drugs such as sulfonylureas, biguanides, 
etc. These drugs have some kind of side effects like nausea, vomiting, 
abdominal pain, diarrhoea, headache, etc., and thus search for a new, 
safe, and potent anti-diabetic herbal formulation is essential to 
overcome these problems. 
MATERIALS AND METHODS 
Herbal medicines are the oldest remedies known to mankind. Herbs 
had been used by all cultures throughout history, but India has one 
of the oldest, richest, and most diverse cultural living traditions 
associated with the use of medicinal plants [3]. Indian plants, which 
are most effective and commonly studied in relation to diabetes and 
its associated complications are Vetiverazizanoidis, Gymnema-
sylvestre, Hemidesmusindicus, Azadirachtaindica, Strychnos 
potatorum, Salacia reticulata, Acasia catechu, Aegle marmelos, 
Holarhena antidysenterica, Cassia auriculata, Trigonella graecum, 
Coccinia indica, and Syzygium cumini [4]. The aim of the present 
study is to develop an anti-diabetic polyherbal formulation without 
any side effects of the traditional allopathic medications and also 
reduce the economic burden of the diabetic patients. With the above 
information in view, “DiaKure”, an indigenous polyherbal 
formulation (containing medicinal plants shown in table 1 below) 
was developed in RVS College of Pharmaceutical Sciences, 
Coimbatore. This formulation has been selected to evaluate its anti-
diabetic activity in this study. 
 
Table 1: Names of the herbs and their families present in polyherbal formulation (DiaKure) 
S. No. Botanical name Family name 
1 Vetiveria zizanioides Graminaceae 
2 Hemidesmus indicus Asclepiadaceae 
3 Strychno spotatrum Loganaceae 
4 Salacia reticulata Hippocrateacea 
5 Acacia catechu Mimosoidaceae 
6 Holarrhena antidysenterica Apocyanaceae 
7 Cassia auriculata Caesalpiniaceae 
8 Trigonella graecum Fabaceae 
 
Animals 
Healthy albino rats of either sex of 2-2½-months-old of body weight 
125-150 g were housed in polypropylene cages at 25±2̊C with light 
dark cycle of 12 h in the Animal House of RVS College of 
Pharmaceutical Sciences. It was acclimatized for seven days. All 
animals were given standard rat feed and water ad libitum [5]. The 
experiments were performed after approval of the protocol by the 
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Institutional Animal Ethics Committee (IAEC) and animal care was 
taken as per the guidelines of Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA), Government 
of India (Registration No. 1012/c/06/CPCSEA). 
Test drug and chemicals 
DiaKure is a poly herbal powder formulation, which contains all the 
herbs as noted in the table 1. All the herbs were collected from an 
herbal store and botanical garden of RVS Ayurveda Hospital, 
Coimbatore. Individual drugs were identified and authenticated by 
comparison with herbarium specimens at Tamil Nadu Agricultural 
University Coimbatore. All the individual herbs were washed and 
dried properly in shade. Dried constituents were made into powder 
in a grinder and sieved properly.  
They were then mixed together to make the poly herbal 
formulation and is stored in an air-tight container free from 
moisture. Streptozotocin was obtained from the Sigma Chemical 
Co., St. Louis, MO, USA. All chemicals used in the study were of 
analytical grade. 
Induction of diabetes in experimental animals 
Experimental diabetes was induced by single i. p. Injection of 60 
mg/kg of streptozotocin (STZ), freshly dissolved in cold citrate 
buffer (pH 4.5) after 15 min of i. p. injection of nicotinamide (110 
mg/kg) prepared in normal saline. Rats with marked glycosuria 
(fasting blood glucose level greater than 200 mg/dL) after one week 
of administration of STZ was used for the study [6]. 
Glucose tolerance test 
The Oral Glucose Tolerance test (OGTT) measures the body’s ability to 
use glucose, which is the body’s main source of energy. Oral glucose 
tolerance test was performed in overnight fasted (18 h) normal rats. 
Normal rats were divided into four groups, each consisting of six rats. 
Group I was normal control (0.5% of CMC solution). Group II and III 
animals received different concentrations of DiaKure viz., 200 mg/kg 
and 300 mg/kg respectively.  
Group IV animals are standard receiving Glibenclamide (GL) 10 mg/kg 
body weight. Groups II and III animals were treated orally with a 
single dose of DiaKure at a dose of 200 mg/kg and 300 mg/kg p. o. 
respectively. Doses were fixed after performing proper toxicological 
evaluations as per OECD guidelines (407,423). Drug was administered 
using oral gavage method. Glucose (2 g/kg) was fed orally through 
orogastric tubes 30 min after the administration of the drug [7]. 
Control animals were administered with equal volume of water. Blood 
was withdrawn from the tail vein at 0, 1, 2, 3 and 4 hr of glucose 
administration and blood glucose levels were determined by the 
glucose oxidase method using glucometer (Accuchek active) [8]. 
Results were tabulated in table 2. The percentage induced glycaemia 
(%IG) following oral glucose load at different time intervals was 
calculated for the control and treated groups as follows. 
%IG = (Gx-Go)/Go × 10 
Where Go is the initial glycemia (mg/dL) and Gx the glycemia 
(mg/dL) at different time intervals after the oral glucose load [9]. 
Hypoglycemic activity 
On the basis of the OGTT studies in normal and diabetic rats, dose 
was selected for STZ-induced diabetic rat model. 
Experimental design 
All diabetic rats were randomly divided into four groups of six rats 
in each groups, 24rats (18 diabetic rats and 6 normal rats). 
Group I–Normal control (0.5% w/v CMC sol.) 
Group II–Diabetic control (0.5% w/v CMC sol.) 
Group III–Streptozotocin+Glibenclamide (10 mg/kg p. o) 
Group IV–Streptozotocin+300 mg/kg body weight of DiaKure. 
The test drug DiaKure was suspended in a vehicle containing 0.5% 
w/v CMC in distilled water and administered orally using an oro-
gastric tube once daily for 20 d. The body weight of the animals was 
measured at the onset of the study and at the regular intervals of 
every week up to 28 d [10]. 
Group I animals were administered orally with distilled water 
whereas group II animals received streptozotocin, group III received 
glibenclamide (10 mg/kg p. o) [11] and group IV received DiaKure 
300 mg/kg body weight for 28 consecutive days.  
The animal dose has been derived from the human dose by using 
standard dose ratios. The blood samples collected from the tail vein 
of rats on 0, 7, 14, 21 and 28 d after administration of formulation. 
The blood glucose levels were determined by the glucose oxidase 
method using glucometer (Accucheck active)[8]. Results were 
tabulated in table 3. 
Statistical analysis 
All values are expressed as mean±SEM. Statistical analysis was 
performed by One-way Anova, analysis of variance (ANOVA) 
followed by Dunnet’s t-test. A ‘p’ value less than 0.05 was considered 
significant. 
Effect of dia kure on glucose-loaded rat (OGTT Model) 
Vehicle treated group and GL (10 mg/kg body wt) treated group 
showed 43.4% and 9.0% rise in serum glucose level (SGL) after one 
hour of glucose administration where as groups II and III showed 
20.5% increase and 21% increase in SGL respectively. From the 
study, it was found out that both 200 mg/kg and 300 mg/kg of 
DiaKure possess significant hypoglycemic activity in normal rats. It 
is found that 200 mg/kg of DiaKure showed a 13% reduction in 
blood glucose at second hour and 300 mg/kg of DiaKure shows 16.5 
% reduction at the same time interval compared to 11.3% decrease 
and 3.4% decrease in control group and GL group respectively, 
shown in table 2.  
Hence, DiaKure 300 mg/kg  dose were selected for further study in 
STZ-induced diabetic rat model. However, all groups of animals almost 
normalized the SGLs within three hours indicating that the pancreas of 
animals was healthy to clear out the glucose load from the body. 
 
Table 2: Effect of DiaKure on serum glucose levels in OGTT model in normal rats 
S. No. Drug/Control Body weight Blood glucose level (mg/dL) 
0 hour 1 hour 2 hour 3 hour 4 hour 
1 Group-1 control (distilled water) 180.0±2.0 92.0±2.5 132.0±3.5 117.0±0 119.0±1.0 100.5±1.5 






























Values are represented as mean±SEM (n=6 rats), Values are statistically significant at *P<0.05,** P<0.01, GL = Glibenclamide. 
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Table 3: Effect of 27 d treatment of Dia Kure on serum glucose levels of STZ-induced diabetic rats 
S. No. Treatment Initial 7th 14 day th 21 day st 28day th day 
1 Normal control 89.3±3.8 91.0±1.5 95.0±1.0 92.8±2.1 89.0±1.7 

























Values are represented as mean±SEM (n=6 rats), Values are statistically significant at ** P<0.01, *** P<0.001. Diabetic+DiaKure compared with 
diabetic+glibenclamide and normal control rats. 
 
Effect of Dia Kure on serum glucose level of diabetic rats 
Diabetic control rats showed the consistent and gradual rise in SGL 
during the study. GL (10 mg/kg body wt) and Dia Kure 300 mg/kg 
treated rats showed a reduction in SGL by 7.1%, 45.5%, 50.1, 53.9%; 
and 12.3%, 33.3%, 49.5%, 59.7% on 7th, 14th, 21st, and 28th day of 
the study and the results were found to be statistically significant 
(P<001) as compared to diabetic control which is shown in table 3. 
The effect was found to be time dependent up to 28th day of the 
study. Decrease in SGL was more significant (P<0.001) on 28th day 
when compared with the standard drug. 
There was also a significant reduction in body weight in diabetic 
animals, however, the animals treated with 300 mg of DiaKure and 
GL showed significant (P<0.001) check on the loss of body weight on 
days 21 and 28 in comparison to the day of onset of the study. This 
effect may be attributed to increased insulin secretion and food 
consumption. This is shown in table 4. These results implied that the 
developed polyherbal formulation DiaKure can reduce the 
complications of body weight and associated cardiovascular risk 
factors during diabetes. 
Toxicity study 
Throughout the study, the animals treated with the developed 
polyherbal formulation DiaKure did not show any behavioral 
changes and mortality, however, a detailed liver function test should 
be conducted to ascertain the risk. 
The poly herbal formulation DiaKure is a mixture of some potent anti-
diabetic herbal drugs. For performing an OGTT, the normal rats were 
treated with 2 mg/kg of oral glucose solution after an overnight fasting. 
Normal rats were used for checking the efficacy of DiaKure. Oral 
ingestion of glucose solution results in an elevated blood sugar level. The 
elevated blood sugar can be reduced with DiaKure administration. 
During OGTT, the blood samples were collected at a time interval of 
0,1,2,3 & 4 h. The glycemic level of DiaKure treated groups at different 
doses are compared with control groups. The experiment showed that 
the body’s ability to maintain the glycemic control may be measured by 
OGTT in normal albino rats. Anti-hyperglycemic effect of DiaKure was 
checked in Streptozotocin-induced diabetic albino rats after an 18 h 
fasting. Glibenclamide 10 mg/kg is used as a standard. The diabetic rats 
were subjected for 28 d study ad libitum. 
 
Table 4: Effect of DiaKure treatment on body weight in STZ-induced diabetic rats on 21st day and 28th day 
S. No. Drug/Control Body weight(g) 
  Baseline 21st day 28th day 
1 Normal control 180.0±2.0 180.9±3.2 182.2±3.1 














Values are represented as mean±SEM (n=6 rats), Values are statistically significant at ** P<0.01, *** P<0.001. Diabetic+DiaKure compared with 
diabetic+glibenclamide and normal control rats. 
 
Streptozotocin is probably the most widely used agents producing 
insulin-dependent diabetes mellitus and non-insulin dependent 
diabetes mellitus in experimental animals. Streptozotocin is a 
glucosamine nitrosourea compound [12]. STZ causes beta cells of 
islets of Langerhans of rats to clearly degenerate. In three days, 
Streptozotocin makes pancreas swell and at last causes 
degeneration in beta cells of islets of Langerhans and induces 
experimental diabetes. It also changes normal metabolism in 
diabetic rats in comparison with normal rats. Consumption of water 
and food, the volume of urine, serum glucose increases in diabetic 
animals in comparison with normal rats, but the levels of serum 
insulin, C-peptide and body weight decreases [13]. The 
characteristic loss of body weight is due to increased muscle wasting 
in diabetes [14]. When diabetic rats were treated with DiaKure, the 
weight loss was put on the check and reversed. 
It is found that DiaKure has significant hypoglycemic effect in 
normoglycemic rats and anti-hyperglycemic effect in streptozotocin-
induced diabetic rats. Expected activity of the drug is compared with 
that of existing marketed antidiabetic drug. 
From the study, it is concluded that the crude polyherbal 
formulation possess significant anti-hyperglycemic activity, which 
can be used effectively to control the elevated blood sugar in 
diabetics. Further studies need to be carried out to find out the 
active principles of the drug and mechanism of action. 
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